Skip to main content
. 2020 Oct 16;35(2):131–147. doi: 10.1038/s41371-020-00426-y

Table 2.

Summary of clinical studies on diastolic function in primary aldosteronism.

Author & year Assessment method Study vs. control group Diastolic function
Rossi et al. (1996) [12] Ei/Ai, ACLVF 34 PA vs. 34 EH PA patients with significantly lower Ei/Ai & higher ACLVF
Rossi et al. (1997) [13] Ei/Ai, ACLVF 26 APA vs. 26 EH APA patients with significantly lower Ei/Ai & higher ACLVF
Tanabi et al. (1997) [15] E/A 20 PA vs. 47 EH No significant difference
Rossi et al. (2002) [16] E/A, ACLVF 17 PA vs. 10 EH PA patients with significantly lower E/A & higher ACLVF
Catena et al. (2007) [62] E/A, DT 54 PA vs. 274 EH PA patients with significantly lower E/A & higher DA
Tsioufis et al. (2008) [130] E/A, DT, Em, Em/Am 17 PA vs. 30 EH E/A & DT no significant difference. PA patients with significant lower Em & Em/Am
Muiesan et al. (2008) [64] E/A, DT 125 PA vs. 125 EH (matched age/sex/BP) No significant difference
Galetta et al. (2009) [78] Em, Am, Em/Am 23 PA vs. 24 EH PA patients with significantly lower Em, higher Am, & lower Em/Am
Lin et al. (2011) [67] Ei/Ai 11 PA vs. 17 EH No significant difference
Lin et al. (2012) [73] Ei/Ai 20 APA vs. 20 EH No significant difference
Su et al. (2012) [80] Tdec in cine MRI 25 PA vs. 12 age-matched healthy subjects PA patients with significantly shorter Tdec
Lee et al. (2013) [81] DT, Ei/Ai 62 PA vs. 17 EH No significant difference
Hung et al. (2015) [84] Em, E/Em 27 APA vs. 27 EH APA patients with significantly lower Em and higher E/Em
Cesari et al. (2016) [71] Em, E/Em 51 PA vs. 61 healthy subjects PA patients with significantly lower Em and higher E/Em
Yang et al. (2017) [72] Em, E/Em 100 PA vs. 100 EH PA patients with significantly lower Em and higher E/Em, but no difference in LVMI compared with EH
Chang et al. (2019) [93] Em, E/Em 105 APA vs. 105 EH matched age, sex, BMI, SBP, DBP, duration of hypertension & number of anti-hypertension drugs APA patients with significantly lower Em and higher E/Em independently of hemodynamic effects

Ei/Ai E wave and A wave flow velocity integral ratio, E/A E wave and A wave flow velocity ratio, ACLVF atrial contribution to left ventricular filling, DT E wave deceleration time, Em peak early diastolic velocity of mitral annulus, Am peak atrial systolic velocity of mitral annulus, BP blood pressure, APA aldosterone-producing adenomas, Tdec time for deceleration of LV volume-time curve, BMI body mass index.